featured
Outcomes of Treatment With Cabozantinib in Patients With HCC After Immune Checkpoint Inhibitor Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
J. Hepatol. 2024 Aug 01;81(2)258-264, SL Chan, BY Ryoo, F Mo, LL Chan, J Cheon, L Li, KH Wong, N Yim, H Kim, C YooFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.